ARTES Biotechnology is a pharmaceutical contract research company specialized in microbial process development and technology transfer. We market the unique METAVAX® (dHepB-VLP) technology in combination with yeast expression. This platform is applicable for large and multimeric antigens and able to create chimeric VLPs. In addition to genetic engineering, the company provides fermentation and downstream process development, analytical assay development and production cell line characterization.